Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MFN2 | O95140 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.42 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27245325 | 1.00 | MFN2 (0.67) | MFN2ALDH1A1GAAHPGDBRD4 | |
| SCHEMBL22315339 | 0.82 | MFN2 (0.86) | MFN2ALDH1A1HPGDTSHRMEN1 | |
| SCHEMBL22289758 | 0.80 | MFN2 (1.00) | MFN2ALDH1A1HPGDTSHRMEN1 | |
| SCHEMBL22620161 | 0.80 | MFN2 (1.00) | MFN2ALDH1A1HPGDTSHRMEN1 | |
| SCHEMBL27245327 | 0.80 | MFN2 (1.00) | MFN2ALDH1A1HPGDTSHRMEN1 | |
| SCHEMBL27245326 | 0.80 | MFN2 (1.00) | MFN2ALDH1A1HPGDTSHRMEN1 | |
| SCHEMBL27245324 | 0.79 | MFN2 (0.65) | MFN2ALDH1A1GAAHPGDBRD4 | |
| SCHEMBL27245328 | 0.79 | MFN2 (0.65) | MFN2ALDH1A1GAAHPGDBRD4 | |
| SCHEMBL29188003 | 0.76 | FFAR4 (0.57) | ALDH1A1TSHRFFAR4 | |
| SCHEMBL17391191 | 0.76 | FFAR4 (0.57) | ALDH1A1TSHRFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199534-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | DORN, GERALD W., II, DR. | 2024-06-20 | — | — | US | disclosed |
| EP-4308540-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | Mitochondria Emotion, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| CN-117377652-A | Cyclopropane analogues of N- (trans-4-hydroxycyclohexyl) -6-phenylhexanamide and related compounds | 线粒体情感状态公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2022198139-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | MITOCHONDRIA EMOTION, INC. (US) | 2022-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199534-A1 | CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS | HAGH, HADHA, NLN | MFN2 135/4885ALDH1A1 884/4885GAA 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.